Figure 3.
Chimerism responses, GVHD, and disease responses following DLI for residual or progressive disease. Results are shown starting from the chimerism result immediately prior to the first DLI dose. Subsequent DLI doses are indicated by the arrows. Further details on patient characteristics and GVHD treatment are shown in Tables 4 and 5. CR indicates complete response; PR, partial response; R, relapse/progression; NR, no response; NC, no change.